ask="4.62"
ask_size="100"
average_daily_volume="195995"
bid="4.00"
bid_size="3000"
book_value="0.74"
change="+0.45"
change_from_200_day_moving_average="1.62"
change_from_50_day_moving_average="1.46"
change_from_52_week_high="-0.28"
change_From_52_week_low="2.92"
change_in_percent="+11.45%"
close="4.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.66"
high_52_weeks="4.66"
last_trade_date="2/21/2017"
last_trade_price="4.38"
last_trade_size="270"
last_trade_time="4:00pm"
low="4.00"
low_52_weeks="1.46"
market_capitalization="149.57M"
moving_average_200_day="2.76"
moving_average_50_day="2.92"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="4.18"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+58.87%"
percent_change_from_50_day_moving_average="+50.01%"
percent_change_from_52_week_high="-6.01%"
percent_change_from_52_week_low="+200.00%"
previous_close="3.93"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.29"
price_per_sales="30.15"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.19"
stock_exchange="NGM"
symbol="FATE"
volume="1291935"
weeks_range_52="1.46 - 4.66"
